Northeast India’s Only English and Hindi Satellite News Channel

Safdarjung Hospital performs its first-ever (CAR) T-cell therapy to treat certain types of lymphoma and blood cancers

First Published: 25th January, 2025 10:50 IST

Dr. Kaushal Kalra said, "The patient has tolerated the treatment well, which is an encouraging outcome for both the patient and the medical team."

The VMMC and Safdarjung Hospital has successfully performed its first-ever Chimeric Antigen Receptor (CAR) T-cell therapy under the leadership of Prof. Sandeep Bansal (Medical Superintendent), a novel treatment for certain types of lymphoma and blood cancers.

According to the statement issued by Safdarjung Hospital, “This significant achievement was made possible by the dedication and expertise of the Department of Medical Oncology, led by the Head of the Department Dr Kaushal Kalra.”

CAR-T cell therapy is an advanced immunotherapy that harnesses the power of a patient’s own immune cells, specifically T-cells, to fight cancer. The T-cells are genetically modified to target and destroy cancerous cells more effectively than the body’s natural immune response. This treatment has proven to be a game-changer for patients with cancers such as non-Hodgkin lymphoma, especially those with refractory or relapsed disease that has not responded to traditional treatments.

“The first CAR-T therapy at Safdarjung Hospital was administered to a patient diagnosed with refractory Non-Hodgkin lymphoma, a type of blood cancer that resists conventional treatments,” the statement added.

Dr. Kaushal Kalra said, “The patient has tolerated the treatment well, which is an encouraging outcome for both the patient and the medical team. This successful case marks a significant milestone in the hospital’s ongoing efforts to provide cutting-edge cancer care. With this achievement, Safdarjung Hospital becomes the first central government hospital in India to offer CAR-T cell therapy, a highly specialized and sophisticated treatment option.”

Dr Sandeep Bansal, the Medical Superintendent of the hospital, expressed his pride in the accomplishment, noting that it underscores the institution’s commitment to providing advanced medical care to patients across the country.

“In North India, only two other government institutions–PGI Chandigarh and AIIMS New Delhi–have performed CAR-T cell therapy, making Safdarjung Hospital a critical player in the growing field of immunotherapy. This accomplishment not only elevates Safdarjung Hospital‘s standing as a leading healthcare institution but also expands access to this life-saving treatment for patients in the public healthcare system,” said Dr Sandeep. (ANI)

COMMENTS

Leave a Reply

Your email address will not be published. Required fields are marked *

WE RECOMMEND

Banner
12 Naxalites killed, 2 jawans dead in encounter in Chhattisgarh’s Bijapur

According to Bastar police officials, the encounter broke out in the forests on Sunday morning.

09th February 2025
Banner
BJP storms to power in Delhi after 27 years with two-thirds majority, AAP reduced to 22 seats

Kailash Gahlot, who left AAP to join BJP months ahead of the polls, won from Bijwasan assembly constituency.

09th February 2025
Banner
Delhi poll results: BJP leads on 36 seats, AAP on 16 in early trend

AAP has gained lead on 16 seats including Chandni Chowk, Rajinder Nagar, Greater Kailash, Trilokpuri, Seemapuri and Babarpur seats.

08th February 2025
Banner
Counting of votes begins for Delhi elections, bypolls in UP’s Milkipur and TN’s Erode seats

Along with Delhi, the counting for by-elections in Uttar Pradesh's Milkipur seat and Tamil Nadu's Erode seat is also underway.

08th February 2025
Banner
Odisha: FIR registered against Rahul Gandhi for ‘anti-national’ remarks

The case was registered at the Jharsuguda Town police station in Odisha under Sections 152 and 197(1)(d) of the Bharatiya Nyaya Sanhita.

08th February 2025